SK3262001A3 - A new composition - Google Patents

A new composition Download PDF

Info

Publication number
SK3262001A3
SK3262001A3 SK326-2001A SK3262001A SK3262001A3 SK 3262001 A3 SK3262001 A3 SK 3262001A3 SK 3262001 A SK3262001 A SK 3262001A SK 3262001 A3 SK3262001 A3 SK 3262001A3
Authority
SK
Slovakia
Prior art keywords
treatment
component
composition
composition according
disorders
Prior art date
Application number
SK326-2001A
Other languages
English (en)
Slovak (sk)
Inventor
John Evenden
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK3262001A3 publication Critical patent/SK3262001A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK326-2001A 1998-09-16 1999-09-13 A new composition SK3262001A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803156A SE9803156D0 (sv) 1998-09-16 1998-09-16 A new composition
PCT/SE1999/001597 WO2000015218A1 (en) 1998-09-16 1999-09-13 A new composition

Publications (1)

Publication Number Publication Date
SK3262001A3 true SK3262001A3 (en) 2001-08-06

Family

ID=20412627

Family Applications (1)

Application Number Title Priority Date Filing Date
SK326-2001A SK3262001A3 (en) 1998-09-16 1999-09-13 A new composition

Country Status (21)

Country Link
EP (1) EP1128825A1 (cs)
JP (1) JP2002524508A (cs)
KR (1) KR20010099647A (cs)
CN (1) CN1317964A (cs)
AR (1) AR021808A1 (cs)
AU (1) AU6378099A (cs)
BR (1) BR9913748A (cs)
CA (1) CA2342341A1 (cs)
CZ (1) CZ2001961A3 (cs)
EE (1) EE200100157A (cs)
HU (1) HUP0103544A3 (cs)
ID (1) ID28785A (cs)
IL (1) IL141519A0 (cs)
IS (1) IS5879A (cs)
NO (1) NO20011312L (cs)
PL (1) PL346763A1 (cs)
SE (1) SE9803156D0 (cs)
SK (1) SK3262001A3 (cs)
TR (1) TR200100779T2 (cs)
WO (1) WO2000015218A1 (cs)
ZA (1) ZA200101946B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE334979T1 (de) 2000-10-13 2006-08-15 Neurosearch As Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
EP1859807A4 (en) * 2005-03-04 2008-04-23 Univ Tokyo Medical & Dental THERAPEUTIC AGENT FOR PREVENTING RECURRENCE OF PSYCHOSTIMULATING INDUCED PSYCHOSIS OR SCHIZOPHRENIA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
PL346763A1 (en) 2002-02-25
ZA200101946B (en) 2002-06-10
CZ2001961A3 (cs) 2001-08-15
HUP0103544A2 (hu) 2002-05-29
EE200100157A (et) 2002-08-15
AU6378099A (en) 2000-04-03
ID28785A (id) 2001-07-05
JP2002524508A (ja) 2002-08-06
WO2000015218A1 (en) 2000-03-23
KR20010099647A (ko) 2001-11-09
NO20011312D0 (no) 2001-03-15
IL141519A0 (en) 2002-03-10
HUP0103544A3 (en) 2003-12-29
AR021808A1 (es) 2002-08-07
CA2342341A1 (en) 2000-03-23
NO20011312L (no) 2001-05-16
TR200100779T2 (tr) 2001-10-22
EP1128825A1 (en) 2001-09-05
SE9803156D0 (sv) 1998-09-16
CN1317964A (zh) 2001-10-17
IS5879A (is) 2001-03-07
BR9913748A (pt) 2001-07-10

Similar Documents

Publication Publication Date Title
US6169098B1 (en) Composition and methods employing it for the treatment of 5-HT-mediated disorders
US20110136865A1 (en) Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
WO2006096434A2 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2006096435A1 (en) Pharmaceutical compositions for the treatment and/or prevention of depression
KR20040030788A (ko) 요실금 치료를 위한 아릴(또는 헤테로아릴)아졸릴카르비놀 유도체
AU2012200A (en) A new pharmaceutical composition
SK3262001A3 (en) A new composition
SK3272001A3 (en) A new composition
WO2008035177A2 (en) Combination of mt1 and mt2 melatonin receptor agonists and a norepinephrine/dopamine reuptake inhibitor
KR100555279B1 (ko) 신경 장애 치료용 제약 조성물
CZ2004739A3 (cs) Použití desoxypeganinu k ošetřování klinické deprese
HRP20010741A2 (en) Use of osanetant in the production of medicaments used to treat mood disorders
SK14502000A3 (sk) Kombinácie liekov n. a. r. i. (inhibítorov reaktivácie noradrenalínu), výhodne reboxetínu, a pindololu
AU6378299A (en) A new composition
JP2002524507A (ja) 新規組成物
MXPA01002370A (en) A new composition
JPH0643307B2 (ja) ジアンヒドロヘキシトールのアシル誘導体
CA2338330A1 (en) Use of moclobemide for treating certain phsychiatric and medical disorders
MXPA01002543A (en) A new composition